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Epidemiological studies point to a strong and possibly causal association of psychiatric and neurological disorders with
cardiovascular disease (CVD). Mechanistic links between these co-occurring illnesses are not well understood. Better insight
into their relationship could help identify novel diagnostic markers and therapeutic targets. For successful translation of basic
biomedical research into clinical practice, analyses of postmortem human tissues are essential. However, current tissue banks
dedicated to psychiatric and neurological research collect only brain tissue samples deemed most important to the institution’s
participating investigators. While this practice is often dictated by budget constraints, restricted tissue storage space and other
practical reasons, it limits the ability of the biological research community to access and study multiple organ systems relevant to
cardiovascularandneuronalsystemsdysfunction.Thisproblemisworsenedwhenclinicalrecordspertainingtocoexistentsystemic
pathologyarenotavailable.Topromotefurtherunderstandingofco-occurringCVDandpsychiatric/neurologicaldisorders,eﬀorts
should be made to support tissue banks that harvest heart, coronary arteries, and aorta samples as well as brain tissue, from the
same subjects.
Copyright © 2009 Milos D. Ikonomovic. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
A growing awareness of the links between diseases of the
cardiovascular system and pathologies of the central nervous
system, including psychiatric and neurological disorders, has
promulgated interest in understanding the pathophysiologi-
calmechanismsunderlyingtheseassociations[1].Itisappar-
ent that studying the brain in isolation hampers understand-
ing the etiology of the most common neurodegenerative
diseases (such as Alzheimer’s disease; AD). This view has led
to reassessment of our current methods of AD research and
increased emphasis on more thorough evaluation of the risk
factors and pathophysiological processes in multiple organ
systems [2].
Extensive eﬀorts have been made to elucidate the role
of elevated serum cholesterol, APOE4 genotype, heart dis-
ease, and cerebral hypoperfusion in the pathogenesis of
AD [3]; however only a few studies have been able to
examine possible correlations between hallmark lesions of
AD and measures of CVD pathology in the same subjects
postmortem. The latter approach has resulted in some
intriguing observations. For example, Beeri and colleagues
reported that indices of coronary artery disease, assessed
histologically postmortem, correlated directly with densities
of neuritic plaques in the hippocampus, entorhinal cortex,
and neocortex [4]. These results supported previous ﬁndings
of a link between AD pathology and coronary artery disease
[5]; but they were not consistent with some other studies
that sought to correlate AD lesions with the extent of CVD
at autopsy [6, 7]. To resolve the controversy, additional
studies utilizing brain, heart, and artery tissues from the
same subject are critical. This could provide new insight into
possible links between cardiovascular and neurodegenerative
diseases, especially when medical records are incomplete and
detailed antemortem assessments of cardiovascular function
(e.g., coronary angiography, electrocardiography) were not
performed in psychiatric and neurological patients who
came to autopsy.
A prominent example of comorbid psychiatric and car-
diovascular disorders is the association between depression
and coronary heart disease (CHD). Depression is associated
with increased cardiovascular morbidity and mortality [8]
and with prominent increases in cardiovascular health
care costs [9]. Despite recent recommendations that all
patientswithCHDbescreenedfordepression[8],additional
research is needed to determine whether existing depression2 Cardiovascular Psychiatry and Neurology
treatments aﬀect cardiac outcomes [10]. Hence, better
understanding of biological mechanisms linking CHD and
depression is needed to direct clinical trials, for example, to
selectthemostappropriatetherapeutictargetsandtreatment
modalities for these comorbid disorders.
It is conceivable that studies using postmortem brain
and heart/vascular tissues from the same subject would
be advantageous to the cardiovascular psychiatry/neurology
research; however such samples are not harvested together
routinely from autopsies of normal and diseased adults.
Considering the complexity of current brain banking eﬀorts
[11, 12], it is not surprising that tissue banks of multiple-
organ autopsy samples from psychiatric and neurological
patients are not readily available. Nevertheless, banking
protocols can be modiﬁed once the need for harvesting
additional tissues has been identiﬁed. For example, the
observation that retinal ganglion cells and their axons are
aﬀected in AD has prompted some Alzheimer’s Disease
Research Center (ADRC) brain banks to start collecting
autopsy samples of retinas and optic nerve. Larger brain
banks that support investigations into speciﬁc neurode-
generative disorders, particularly those banks structured
within the ADRC or other large National Institutes of
Health-funded initiatives for longitudinal studies of the
elderly and AD, have the advantage of being able to obtain
brain and spinal cord autopsy samples, the subject’s blood
and cerebrospinal ﬂuid samples, and detailed antemortem
clinical and imaging data. Ideally, banking eﬀorts would
be extended to include additional organs and tissues, such
as the heart and blood vessels, to their specimens. The
Brain Bank of the Brazilian Aging Brain Study Group has
undertaken such an ambitious multiorgan banking project.
This tissue bank has collected more than 1600 brains
and has implemented an autopsy protocol for harvesting
additional organs/tissues such as heart, cervical carotids,
and kidneys [13]. Carotid, coronary, and Willis’ Circle
arteries are evaluated for atherosclerosis, and heart valves
and ventricular muscle are examined for chronic eﬀects
of hypertension. To establish successful tissue banking
resources of such magnitude, great dedication and eﬀort
will be needed from researchers as well as willing donors.
Some of the cohorts that would be particularly valuable
for planning the brain-heart donation protocol include
participants in prospective studies of CVD and dementia
[14].
Several issues should be considered before initiating the
extension of an existing brain bank into a multiorgan bank.
First, a detailed and comprehensive protocol would have to
be formulated to ensure standardized sampling procedures
from multiple organs. Next, a dedicated and adequate source
of funding must be secured; tight budgets combined with
insuﬃcient personnel and tissue storage capacities of most
brainbanksintheUSAandabroadrestrictlargescalestorage
of harvested tissues. Finally, greater eﬀorts must be made to
promote collaborations of basic and clinical neuroscientists
with experts in CVD. These collaborations are invaluable
in the light of the co-occurrence of cardiovascular and
psychiatric/neurological disorders as well as the progressive
multisystem dysfunction that accompanies cognitive decline
in many elderly individuals. By expanding our existing
brain tissue banks to accommodate the emerging need
for a multiorgan/tissue oriented research, multidisciplinary
collaborations would be fostered to provide broader insight
intothediseaseprocess.Thiscouldbeachievedbyrequesting
improved funding for such initiatives, along with matching
education and outreach eﬀorts to ensure greater public
support for such projects.
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